Skip to content

Lung Cancer Screening Eligibility Assessment

Using a Simplified Tool to Predict Lung Cancer Screening (LCS) Eligibility: Experiment to Test Effects of Messaging on Response Rates

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06133816
Enrollment
6125
Registered
2023-11-18
Start date
2023-07-31
Completion date
2024-01-31
Last updated
2025-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Lung Cancer Screening

Brief summary

The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate pack-year eligibility for lung cancer screening (LCS). This will help inform the best way to increase response rates to the tool in future intervention studies designed to increase LCS, and expand upon survey methodology in general.

Detailed description

Despite growing evidence that lung cancer screening (LCS) reduces lung cancer-specific mortality, LCS across the United States is remarkably low. This is due in part to challenges with identifying adults who meet eligibility criteria for lifetime smoking intensity (i.e., 20 pack-years or greater), which is often missing from the electronic medical record. We have developed a simplified eligibility tool that has shown accuracy in estimating pack-years. But given the potential for low response rates, there is a great need to identify effective strategies to increasing response rates equitably prior to using it in practice or in future studies. The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate pack-year eligibility for lung cancer screening (LCS). This will help to identify the best way to increase response rates to the tool in future intervention studies designed to increase LCS, and expand upon survey methodology in general.

Interventions

BEHAVIORALFramed Introductory Message A

Randomly assign patients to receive introductory message encouraging them to complete the survey (version A).

BEHAVIORALFramed Introductory Message B

Randomly assign patients to receive introductory message encouraging them to complete the survey (version B).

BEHAVIORALFramed Introductory Message C

Randomly assign patients to receive introductory message encouraging them to complete the survey (version C).

BEHAVIORALFramed Tobacco Use Message A

Randomly assign patients to receive norming message related to tobacco use (version A).

BEHAVIORALFramed Tobacco Use Message B

Randomly assign patients to receive norming message related to tobacco use (version B).

BEHAVIORALFinancial Incentive

Randomly assigned patients to be entered into a drawing to receive a $100 gift card.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Cancer Institute (NCI)
CollaboratorNIH
Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Intervention model description

We will use a randomized factorial design to test the effects of different types of messaging with or without incentives on response rates to an eligibility survey.

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. meet age eligibility (50-80 years old) for LCS based on 2021 USPSTF guidelines; and 2. have completed at least one primary care visit at Penn Medicine in 2020-2025

Exclusion criteria

1. have a documented history of lung cancer; 2. have a documented history of completing LCS at Penn Medicine; 3. are listed as not wanting to be contacted or solicited for research; or 4. do not otherwise meet inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Full Survey Completion7 daysThe proportion of participants that answers all three survey questions via text message among all those randomized.

Secondary

MeasureTime frameDescription
Partial Survey Completion7 daysThe proportion of participants that answer at least one of three survey questions via text message among all those randomized.

Countries

United States

Participant flow

Pre-assignment details

No significant events

Participants by arm

ArmCount
Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)
Participants will receive two framed messages (AA) plus an incentive Framed Introductory Message A: Randomly assign patients to receive introductory message encouraging them to complete the survey (version A). Framed Tobacco Use Message A: Randomly assign patients to receive norming message related to tobacco use (version A). Financial Incentive: Randomly assigned patients to be entered into a drawing to receive a $100 gift card.
509
Arm 2 (Introductory Message A + Tobacco Use Message A)
Participants will receive two framed messages (AA) Framed Introductory Message A: Randomly assign patients to receive introductory message encouraging them to complete the survey (version A). Framed Tobacco Use Message A: Randomly assign patients to receive norming message related to tobacco use (version A).
509
Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)
Participants will receive two framed messages (AB) plus an incentive Framed Introductory Message A: Randomly assign patients to receive introductory message encouraging them to complete the survey (version A). Framed Tobacco Use Message B: Randomly assign patients to receive norming message related to tobacco use (version B). Financial Incentive: Randomly assigned patients to be entered into a drawing to receive a $100 gift card.
515
Arm 4 (Introductory Message A + Tobacco Use Message B)
Participants will receive two framed messages (AB) Framed Introductory Message A: Randomly assign patients to receive introductory message encouraging them to complete the survey (version A). Framed Tobacco Use Message B: Randomly assign patients to receive norming message related to tobacco use (version B).
509
Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)
Participants will receive two framed messages (BA) plus an incentive Framed Introductory Message B: Randomly assign patients to receive introductory message encouraging them to complete the survey (version B). Framed Tobacco Use Message A: Randomly assign patients to receive norming message related to tobacco use (version A). Financial Incentive: Randomly assigned patients to be entered into a drawing to receive a $100 gift card.
510
Arm 6 (Introductory Message B + Tobacco Use Message A)
Participants will receive two framed messages (BA) Framed Introductory Message B: Randomly assign patients to receive introductory message encouraging them to complete the survey (version B). Framed Tobacco Use Message A: Randomly assign patients to receive norming message related to tobacco use (version A).
510
Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)
Participants will receive two framed messages (BB) plus an incentive Framed Introductory Message B: Randomly assign patients to receive introductory message encouraging them to complete the survey (version B). Framed Tobacco Use Message B: Randomly assign patients to receive norming message related to tobacco use (version B). Financial Incentive: Randomly assigned patients to be entered into a drawing to receive a $100 gift card.
512
Arm 8 (Introductory Message B + Tobacco Use Message B)
Participants will receive two framed messages (BB) Framed Introductory Message B: Randomly assign patients to receive introductory message encouraging them to complete the survey (version B). Framed Tobacco Use Message B: Randomly assign patients to receive norming message related to tobacco use (version B).
509
Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)
Participants will receive two framed messages (CA) plus an incentive Framed Introductory Message C: Randomly assign patients to receive introductory message encouraging them to complete the survey (version C). Framed Tobacco Use Message A: Randomly assign patients to receive norming message related to tobacco use (version A). Financial Incentive: Randomly assigned patients to be entered into a drawing to receive a $100 gift card.
511
Arm 10 (Introductory Message C + Tobacco Use Message A)
Participants will receive two framed message (CA) Framed Introductory Message C: Randomly assign patients to receive introductory message encouraging them to complete the survey (version C). Framed Tobacco Use Message A: Randomly assign patients to receive norming message related to tobacco use (version A).
511
Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)
Participants will receive two framed messages (CB) plus an incentive Framed Introductory Message C: Randomly assign patients to receive introductory message encouraging them to complete the survey (version C). Framed Tobacco Use Message B: Randomly assign patients to receive norming message related to tobacco use (version B). Financial Incentive: Randomly assigned patients to be entered into a drawing to receive a $100 gift card.
509
Arm 12 (Introductory Message C + Tobacco Use Message B)
Participants will receive two framed messages (CB) Framed Introductory Message C: Randomly assign patients to receive introductory message encouraging them to complete the survey (version C). Framed Tobacco Use Message B: Randomly assign patients to receive norming message related to tobacco use (version B).
511
Total6,125

Baseline characteristics

CharacteristicArm 1 (Introductory Message A + Tobacco Use Message A + Incentive)Arm 2 (Introductory Message A + Tobacco Use Message A)Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)Arm 4 (Introductory Message A + Tobacco Use Message B)Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)Arm 6 (Introductory Message B + Tobacco Use Message A)Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)Arm 8 (Introductory Message B + Tobacco Use Message B)Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)Arm 10 (Introductory Message C + Tobacco Use Message A)Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)Arm 12 (Introductory Message C + Tobacco Use Message B)Total
Age, Continuous65.02 years
STANDARD_DEVIATION 0.35
64.33 years
STANDARD_DEVIATION 0.33
64.50 years
STANDARD_DEVIATION 0.33
64.48 years
STANDARD_DEVIATION 0.34
64.15 years
STANDARD_DEVIATION 0.33
64.67 years
STANDARD_DEVIATION 0.34
64.21 years
STANDARD_DEVIATION 0.33
63.33 years
STANDARD_DEVIATION 0.35
64.56 years
STANDARD_DEVIATION 0.33
64.28 years
STANDARD_DEVIATION 0.36
64.40 years
STANDARD_DEVIATION 0.33
63.89 years
STANDARD_DEVIATION 0.32
64.32 years
STANDARD_DEVIATION 0.1
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants14 Participants15 Participants11 Participants16 Participants10 Participants8 Participants15 Participants16 Participants9 Participants9 Participants6 Participants136 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
502 Participants495 Participants500 Participants498 Participants494 Participants500 Participants504 Participants494 Participants495 Participants502 Participants500 Participants505 Participants5989 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants2 Participants0 Participants2 Participants2 Participants0 Participants1 Participants1 Participants4 Participants3 Participants4 Participants21 Participants
Race (NIH/OMB)
Asian
6 Participants6 Participants6 Participants12 Participants8 Participants8 Participants10 Participants8 Participants5 Participants7 Participants14 Participants7 Participants97 Participants
Race (NIH/OMB)
Black or African American
94 Participants94 Participants95 Participants93 Participants95 Participants95 Participants95 Participants94 Participants94 Participants94 Participants94 Participants94 Participants1131 Participants
Race (NIH/OMB)
More than one race
12 Participants13 Participants10 Participants11 Participants11 Participants12 Participants13 Participants14 Participants15 Participants9 Participants13 Participants14 Participants147 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants0 Participants0 Participants0 Participants1 Participants0 Participants0 Participants0 Participants1 Participants0 Participants0 Participants0 Participants3 Participants
Race (NIH/OMB)
Unknown or Not Reported
26 Participants23 Participants37 Participants33 Participants32 Participants31 Participants27 Participants34 Participants32 Participants28 Participants26 Participants39 Participants368 Participants
Race (NIH/OMB)
White
369 Participants372 Participants365 Participants360 Participants361 Participants362 Participants367 Participants358 Participants363 Participants369 Participants359 Participants353 Participants4358 Participants
Sex: Female, Male
Female
259 Participants260 Participants261 Participants258 Participants259 Participants259 Participants261 Participants258 Participants260 Participants259 Participants258 Participants260 Participants3112 Participants
Sex: Female, Male
Male
250 Participants249 Participants254 Participants251 Participants251 Participants251 Participants251 Participants251 Participants251 Participants252 Participants251 Participants251 Participants3013 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
EG008
affected / at risk
EG009
affected / at risk
EG010
affected / at risk
EG011
affected / at risk
deaths
Total, all-cause mortality
0 / 5090 / 5090 / 5150 / 5090 / 5100 / 5100 / 5120 / 5090 / 5110 / 5110 / 5090 / 511
other
Total, other adverse events
0 / 5090 / 5090 / 5150 / 5090 / 5100 / 5100 / 5120 / 5090 / 5110 / 5110 / 5090 / 511
serious
Total, serious adverse events
0 / 5090 / 5090 / 5150 / 5090 / 5100 / 5100 / 5120 / 5090 / 5110 / 5110 / 5090 / 511

Outcome results

Primary

Full Survey Completion

The proportion of participants that answers all three survey questions via text message among all those randomized.

Time frame: 7 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)Full Survey Completion358 Participants
Arm 2 (Introductory Message A + Tobacco Use Message A)Full Survey Completion381 Participants
Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)Full Survey Completion383 Participants
Arm 4 (Introductory Message A + Tobacco Use Message B)Full Survey Completion389 Participants
Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)Full Survey Completion372 Participants
Arm 6 (Introductory Message B + Tobacco Use Message A)Full Survey Completion399 Participants
Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)Full Survey Completion386 Participants
Arm 8 (Introductory Message B + Tobacco Use Message B)Full Survey Completion402 Participants
Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)Full Survey Completion335 Participants
Arm 10 (Introductory Message C + Tobacco Use Message A)Full Survey Completion397 Participants
Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)Full Survey Completion373 Participants
Arm 12 (Introductory Message C + Tobacco Use Message B)Full Survey Completion366 Participants
Secondary

Partial Survey Completion

The proportion of participants that answer at least one of three survey questions via text message among all those randomized.

Time frame: 7 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)Partial Survey Completion377 Participants
Arm 2 (Introductory Message A + Tobacco Use Message A)Partial Survey Completion405 Participants
Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)Partial Survey Completion394 Participants
Arm 4 (Introductory Message A + Tobacco Use Message B)Partial Survey Completion403 Participants
Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)Partial Survey Completion381 Participants
Arm 6 (Introductory Message B + Tobacco Use Message A)Partial Survey Completion414 Participants
Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)Partial Survey Completion403 Participants
Arm 8 (Introductory Message B + Tobacco Use Message B)Partial Survey Completion408 Participants
Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)Partial Survey Completion345 Participants
Arm 10 (Introductory Message C + Tobacco Use Message A)Partial Survey Completion413 Participants
Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)Partial Survey Completion383 Participants
Arm 12 (Introductory Message C + Tobacco Use Message B)Partial Survey Completion385 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026